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Importance 
Equine piroplasmosis is a tick-borne protozoal infection of horses. Piroplasmosis 
may be difficult to diagnose, as it can cause variable and nonspecific clinical signs. The 
symptoms of this disease range from acute fever, inappetence and malaise, to anemia 
and jaundice, sudden death, or chronic weight loss and poor exercise tolerance. 
Piroplasmosis is a major constraint to the international movement of equines. Although 
this disease was formerly endemic in Florida, the organisms were eradicated by the 
1980s and piroplasmosis is considered to be an exotic disease in the United States. 
However, false negatives can occur in the complement fixation test, which was used for 
import testing until 2005, and there is a possibility that some horses in the U.S. might be 
inapparent carriers. In 2008, an outbreak occurred at a facility in Florida, highlighting 
the need to maintain constant vigilance for this disease. 
Etiology 
Equine piroplasmosis results from infection by the protozoa Babesia caballi or 
Theileria equi (formerly Babesia equi). Both organisms belong to the phylum 
Apicomplexa and order Piroplasmida. They can infect an animal concurrently.  
Other related protozoa such as Babesia bovis (the organism that causes bovine 
babesiosis) have been reported rarely in horses. 
Species Affected 
Equine piroplasmosis affects horses, mules, donkeys and zebras. Zebras are an 
important reservoir for infection in Africa. 
Geographic Distribution 
The parasites that cause equine piroplasmosis are endemic in many tropical and 
subtropical regions including parts of Africa, the Middle East, Asia, Central and 
South America, the Caribbean and Europe. To a lesser extent, they may be found in 
temperate areas. T. equi is thought to have a wider distribution than B. caballi. 
Australia, New Zealand, Canada, Japan and some other countries are free of these 
parasites. Equine piroplasmosis was eradicated from the United States by the 1980s, 
and it is considered to be an exotic disease. However, false negatives can occur in the 
complement fixation test, which was used for import testing in the U.S. until 2004/ 
2005, and there is a possibility that some horses might be inapparent carriers. Other 
piroplasmosis-free countries that used this test could also have some carriers. 
Transmission 
B. caballi and T. equi are transmitted by ticks, which become infected when they 
ingest parasites in the blood of infected equids. Approximately 14 species of ticks in 
the genera Dermacentor, Hyalomma and Rhipicephalus can be vectors for these 
organisms; however, the epidemiological significance of some species is unknown. 
Potential tick vectors for T. equi and B. caballi exist in the U.S. 
Although ticks are biological vectors for both T. equi and B. caballi, differences 
in these parasites’ replication cycles can affect their methods of transmission. Inside 
the tick, Babesia zygotes multiply as ‘vermicules,’ which invade many of the tick’s 
organs including the ovaries, and Babesia species are readily passed to the next 
generation of ticks in the egg (transovarial transmission). When an infected larval, 
nymphal or adult tick of the next generation attaches to a new host, the parasite is 
stimulated to undergo its final maturation, allowing it to infect the host. In contrast, 
Theileria zygotes do not multiply in the tick, and transovarial transmission of T. equi 
is uncertain or absent. Ticks that transmit this organism can become infected as larvae 
and transmit the infection as nymphs, or they can become infected as nymphs and 
transmit the infection as adults (transstadial transmission). In some species of ticks 
such as Rhipicephalus microplus (formerly Boophilus microplus), T. equi can also be 
transmitted by the same tick stage that acquired the parasite (intrastadial 
transmission); whether this occurs in other species of ticks is unknown. Ticks infected 
with Theileria lose these parasites after transmission. Like B. caballi, T. equi parasites 
only stimulated to complete their maturation after the tick attaches to feed. For this 
reason, a tick infected with either organism must remain attached to the host for a time  
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before it becomes infective; often, B. caballi and T. equi are 
transmitted after the tick has been attached for a few days. 
Equine piroplasmosis can also be transmitted directly 
between animals by contaminated needles and syringes, or 
by blood transfusions.  
After recovery, horses may become carriers for long 
periods. Animals infected with B. caballi can remain 
carriers for up to 4 years, but might be able to clear the 
organism eventually. Equids infected with T. equi appear to 
remain permanently infected. Parasitemia is often absent in 
carriers, but can reoccur after immuno-suppression or 
strenuous exercise. T. equi can be passed to the foal in 
utero, and some foals can be healthy carriers. 
Transplacental transmission of B. caballi has rarely been 
reported, and some sources consider the evidence for this 
route to be unreliable. 
Incubation Period 
The incubation period for equine piroplasmosis is 12 to 
19 days when it is caused by T. equi, and 10 to 30 days 
when it is caused by B. caballi. 
Clinical Signs 
The clinical signs of piroplasmosis are variable and 
often nonspecific. T. equi tends to cause more severe 
disease than B. caballi.  
In rare peracute cases, animals may be found dead or 
dying. More often, piroplasmosis presents as an acute 
infection, with fever, inappetence, malaise, labored or rapid 
respiration and congestion of the mucus membranes. The 
feces may be small and dry, but diarrhea has also been 
reported. Anemia, thrombocytopenia, jaundice, 
hemoglobinuria, sweating, petechial hemorrhages on the 
conjunctiva, a swollen abdomen, and posterior weakness or 
swaying may also be seen. Subacute cases have similar but 
less severe clinical signs. The fever may be intermittent, 
and animals may show weight loss, signs of mild colic, and 
mild edema of the distal limbs. The mucus membranes in 
subacute cases can be pink, pale pink or yellow, and they 
may have petechiae or ecchymoses. In chronic cases, 
common symptoms include mild inappetence, poor exercise 
tolerance, weight loss, transient fevers and an enlarged 
spleen (palpable on rectal examination). Some infected 
mares, including carrier mares, may abort or pass T. equi to 
their offspring. Foals infected in utero may be weak at 
birth, and rapidly develop anemia and severe jaundice. In 
other cases, these foals can be healthy carriers. 
Asymptomatic carriers can develop clinical signs after 
immunosuppression or strenuous exercise. 
Post Mortem Lesions      Click to view images 
In acute cases, the animal is usually emaciated, 
jaundiced and anemic. The liver is typically enlarged and 
may be either dark orange-brown or pale from anemia. The 
spleen is enlarged. The kidneys may be pale and flabby, or 
they may be dark red or black if the animal had 
hemoglobinuria. Petechial hemorrhages may be seen in the 
kidneys and subepicardial and subendocardial hemorrhages 
in the heart. Secondary infections may cause edema, 
emphysema or signs of pneumonia in the lungs. 
Morbidity and Mortality 
In some areas, equine piroplasmosis is most common 
in the summer and fall; however, even in these regions, 
cases can occur throughout the year. In some endemic areas 
where tick control is not practiced, nearly all horses are 
eventually exposed to B. caballi. Reported case fatality 
rates for equine piroplasmosis vary; one source suggests 
that the mortality rate can vary from less than 10% to as 
high as 50%. 
Diagnosis 
Clinical 
Equine piroplasmosis should be suspected in horses 
with anemia, jaundice and fever; however, the clinical signs 
are often variable and nonspecific. 
Differential diagnosis 
The differential diagnosis for piroplasmosis includes 
surra, equine infectious anemia, dourine, African horse 
sickness, purpura hemorrhagica, and various plant and 
chemical toxicities. 
Laboratory tests 
Equine piroplasmosis can be diagnosed by identification 
of the organisms in Giemsa stained blood or organ smears. B. 
caballi merozoites are joined at their posterior ends, while T. 
equi merozoites are often connected in a tetrad or “Maltese 
cross.” T. equi can often be found in the blood in acute 
infections, but may be very difficult to find in carrier animals. 
B. caballi can sometimes be difficult to find even in acute 
disease. In carriers or other animals with low parasitemia, 
thick blood films can sometimes be helpful.  
Because organisms can be difficult to detect in carriers, 
serology is often used for diagnosis. Serological tests 
include complement fixation (CF), indirect fluorescent 
antibody (IFA) and various enzyme-linked immunosorbent 
(ELISA) assays. Immunoblotting (Western blotting) can 
also be used, and an immunochromatographic test for T. 
equi has been described. The complement fixation test can 
be affected by natural anticomplementary activity in serum, 
as well as drug treatment or other factors; some carriers can 
be negative in this test. Animals do not become CF-positive 
for at least a month after inoculation. For these reasons, the 
IFA test and competitive ELISA (C-ELISA) have replaced 
complement fixation for import testing The IFA test can 
distinguish T. equi from B. caballi.  
Polymerase chain reaction (PCR) assays are available 
in some laboratories. Additional molecular techniques 
include nested PCR, multiplex PCR and loop-mediated 
isothermal amplification (LAMP).  
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Other methods of diagnosis are in vitro culture and the 
inoculation of a susceptible (preferably splenectomized) 
animal with blood from a suspected carrier. In addition, 
pathogen-free vector ticks can be fed on a suspect animal, 
and B. caballi or T. equi identified either in the tick or after 
the tick has transmitted the infection to a susceptible animal. 
These methods can detect B caballi and T. equi when other 
techniques do not find the parasites. They can be particularly 
useful in carriers. 
Samples to collect 
Before collecting or sending any samples from 
animals with a suspected foreign animal disease, the 
proper authorities should be contacted. Samples should 
only be sent under secure conditions and to authorized 
laboratories to prevent the spread of the disease. Animal 
Babesia or Theileria species have been implicated in 
human infections; samples should be collected and 
handled with all appropriate precautions. 
Several thick and thin blood smears or an unclotted 
blood sample should be taken from live animals. Blood 
smears are optimally made from superficial skin capillaries 
during the acute phase of the disease. If possible, these 
samples should be collected during a rise in body 
temperature. Organ smears can be collected at necropsy. 
Slides should be air-dried and fixed in methanol. Serum 
should also be taken for serology. Larger amounts of blood 
are necessary for transmission tests to a susceptible horse; 
one source recommends that 500 ml uncoagulated blood 
(with antibiotics added) should be collected. Samples 
should be transported on wet ice or with frozen gel packs. 
Recommended actions if equine 
piroplasmosis is suspected 
Notification of authorities 
Equine piroplasmosis is exotic to the U.S. and must be 
reported immediately to state or federal authorities. 
Federal: Area Veterinarians in Charge (AVIC): 
http://www.aphis.usda.gov/animal_health/area_offices/ 
State Veterinarians:   
http://www.usaha.org/Portals/6/StateAnimalHealthOfficia
ls.pdf 
Control  
Carrier animals or infected ticks can introduce equine 
piroplasmosis into new regions. Equids are usually tested 
for this disease during importation. IFA and ELISA tests 
are highly sensitive, but complement fixation may not 
detect all carriers. 
Disinfectants and sanitation are not generally effective 
against the spread of tick-borne infections. However, 
eliminating contact with ticks and preventing the transfer of 
blood from one animal to another are vital. In endemic 
areas, the use of acaricides, together with frequent 
examination of the animal and immediate removal of any 
ticks (parasite transmission does not occur immediately), 
may help prevent infection.  
If an infected animal is discovered in a piroplasmosis-
free region, the animal must be quarantined and kept from 
all contact with ticks. Strict precautions should be taken to 
prevent contact between horses and ticks, whenever carriers 
are admitted to a piroplasmosis-free country for an 
international competition. These measures can include 
spraying the premises repeatedly with acaricides, 
eliminating vegetation from these areas, and maintaining 
infected horses in a separate quarantine area except during 
competition and other specified activities. Pets, wildlife and 
rodents should be excluded from these areas. Horses should 
be inspected daily for ticks and may be treated with 
acaricidal sprays and shampoos. Ticks could hide in animal 
wastes, which should be destroyed and not allowed to leave 
the quarantine area. Sentinel horses may be used to monitor 
the effectiveness of these controls. 
Treatment can suppress clinical signs, but the currently 
available treatments are ineffective in clearing T. equi from 
carriers. Some studies have suggested that treatment could 
eliminate B. caballi from infected horses; however, in a 
recent study, this organism persisted in carriers after even 
high dose treatment with imidocarb. Although this drug 
could temporarily clear the parasites and resulted in 
transiently negative PCR results, B. caballi DNA was found 
in horses after the treatment ended. There is no vaccine for 
either B. caballi or T. equi.  
Public Health 
Some species of Babesia or Theileria can occasionally 
infect species other than their usual host, including humans. 
To date, the most important pathogens for humans appear to 
be the bovine pathogen B. divergens in Europe and the 
rodent species B. microti in the U.S. Although B. caballi or 
T. equi may have been implicated in a few human 
infections in the past, these organisms do not seem to be 
important zoonoses. However, human babesiosis is still 
incompletely understood, and the possibility of infection 
with these organisms has not been ruled out.  
Humans usually acquire Babesia species from ticks, 
but infections have also been reported after receiving 
transfusions of infected blood. The form of the disease can 
vary with the species of Babesia and the 
immunocompetence of the host. In most healthy, 
immunocompetent individuals, babesiosis tends to be mild 
or asymptomatic, and the symptoms often resolve without 
treatment. B. divergens has been mainly associated with 
illness in splenectomized individuals, and B. microti 
infections are often diagnosed in older patients. In humans, 
babesiosis is characterized by fever, chills, anemia, fatigue 
and headache. Jaundice, hemoglobinuria, neurological 
signs, and complications such as congestive heart failure, 
disseminated intravascular coagulation, kidney failure or 
respiratory distress syndrome may also be seen. Some 
infections can be rapidly progressive and fatal. Coinfection 
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with Babesia can also increase the severity of diseases such 
as Lyme disease. Human babesiosis can be treated with 
antibiotics. 
Internet Resources 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp  
United States Animal Health Association.  
Foreign Animal Diseases  
http://www.aphis.usda.gov/emergency_response/downl
oads/nahems/fad.pdf  
World Organization for Animal Health (OIE)  
http://www.oie.int  
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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